| Literature DB >> 32188632 |
Marco Monroy1, Anna L McCarter1, Devon Hominick1, Nina Cassidy1, Michael T Dellinger2,3.
Abstract
Bones do not normally have lymphatics. However, individuals with generalized lymphatic anomaly (GLA) or Gorham-Stout disease (GSD) develop ectopic lymphatics in bone. Despite growing interest in the development of tissue-specific lymphatics, the cellular origin of bone lymphatic endothelial cells (bLECs) is not known and the development of bone lymphatics has not been fully characterized. Here, we describe the development of bone lymphatics in mouse models of GLA and GSD. Through lineage-tracing experiments, we show that bLECs arise from pre-existing Prox1-positive LECs. We show that bone lymphatics develop in a stepwise manner where regional lymphatics grow, breach the periosteum and then invade bone. We also show that the development of bone lymphatics is impaired in mice that lack osteoclasts. Last, we show that rapamycin can suppress the growth of bone lymphatics in our models of GLA and GSD. In summary, we show that bLECs can arise from pre-existing LECs and that rapamycin can prevent the growth of bone lymphatics.Entities:
Keywords: Generalized lymphatic anomaly; Gorham-Stout disease; PIK3CA; Rapamycin; VEGF-C
Mesh:
Substances:
Year: 2020 PMID: 32188632 PMCID: PMC7188445 DOI: 10.1242/dev.184291
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868